ATE543915T1 - Zusammensetzungen und verfahren zur bestimmung der empfindlichkeit eines pathogenen virus gegenüber proteaseinhibitoren - Google Patents

Zusammensetzungen und verfahren zur bestimmung der empfindlichkeit eines pathogenen virus gegenüber proteaseinhibitoren

Info

Publication number
ATE543915T1
ATE543915T1 AT03742733T AT03742733T ATE543915T1 AT E543915 T1 ATE543915 T1 AT E543915T1 AT 03742733 T AT03742733 T AT 03742733T AT 03742733 T AT03742733 T AT 03742733T AT E543915 T1 ATE543915 T1 AT E543915T1
Authority
AT
Austria
Prior art keywords
sensitivity
compositions
determining
methods
protease inhibitors
Prior art date
Application number
AT03742733T
Other languages
English (en)
Inventor
Neil Parkin
Colombe Chappey
Christos Petropoulos
Original Assignee
Monogram Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monogram Biosciences Inc filed Critical Monogram Biosciences Inc
Application granted granted Critical
Publication of ATE543915T1 publication Critical patent/ATE543915T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AT03742733T 2002-02-15 2003-02-14 Zusammensetzungen und verfahren zur bestimmung der empfindlichkeit eines pathogenen virus gegenüber proteaseinhibitoren ATE543915T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35717102P 2002-02-15 2002-02-15
US35934202P 2002-02-22 2002-02-22
US39237702P 2002-06-26 2002-06-26
PCT/US2003/004362 WO2003070700A2 (en) 2002-02-15 2003-02-14 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors

Publications (1)

Publication Number Publication Date
ATE543915T1 true ATE543915T1 (de) 2012-02-15

Family

ID=27761425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03742733T ATE543915T1 (de) 2002-02-15 2003-02-14 Zusammensetzungen und verfahren zur bestimmung der empfindlichkeit eines pathogenen virus gegenüber proteaseinhibitoren

Country Status (10)

Country Link
US (1) US7384734B2 (de)
EP (1) EP1483416B1 (de)
CN (1) CN1646704A (de)
AR (1) AR038557A1 (de)
AT (1) ATE543915T1 (de)
AU (1) AU2003211026A1 (de)
CA (1) CA2476403C (de)
ES (1) ES2381866T3 (de)
TW (1) TW200303362A (de)
WO (1) WO2003070700A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030108857A1 (en) * 2001-06-04 2003-06-12 Parkin Neil T. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
US6869759B1 (en) 1999-06-22 2005-03-22 Virologic, Inc. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
US7186506B1 (en) 2000-06-12 2007-03-06 Monogram Biosciences, Inc. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
US7138231B2 (en) 2000-09-15 2006-11-21 Monogram Biosciences, Inc. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
US7384734B2 (en) 2002-02-15 2008-06-10 Monogram Biosciences, Inc. Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
CN1678755A (zh) 2002-07-01 2005-10-05 瓦罗洛吉克公司 确定致病性病毒对蛋白酶抑制剂易感性的组合物和方法
CA2491388A1 (en) 2002-07-01 2004-01-08 Virologic, Inc. Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
US20050148523A1 (en) * 2003-12-15 2005-07-07 Colonno Richard J. Method of treating HIV infection in atazanavir-resistant patients using a combination of atazanavir and another protease inhibitor
WO2007084618A2 (en) * 2006-01-19 2007-07-26 Monogram Biosciences, Inc. Method for determining resistance of hiv to protease inhibitor treatment
EP2121589A2 (de) * 2006-12-18 2009-11-25 University of Massachusetts Kristallstrukturen von an hiv-1-protease gebundene hiv-1-proteaseinhibitoren
CN101790682B (zh) * 2007-03-30 2016-10-19 9898有限公司 发展自然产物的药用平台的技术
MX2009013461A (es) * 2007-06-22 2010-01-15 Bristol Myers Squibb Co Composiciones comprimidas que contienen atazanavir.
US20100178340A1 (en) * 2007-06-22 2010-07-15 Bristol-Myers Squibb Company Tableted compositions containing atazanavir
AU2008268627A1 (en) * 2007-06-22 2008-12-31 Bristol-Myers Squibb Company Tableted compositions containing atazanavir
SI2170292T1 (sl) * 2007-06-22 2014-05-30 Bristol-Myers Squibb Holdings Ireland Tabletirani sestavki, ki vsebujejo atazanavir
US10480037B2 (en) 2011-09-23 2019-11-19 Laboratory Corporation Of America Holdings Methods and systems for predicting HIV-1 coreceptor tropism
CN103215348B (zh) * 2013-03-19 2015-06-03 浙江大学 Hiv-1病毒蛋白酶抑制剂耐药突变检测试剂盒及方法
WO2018096153A1 (en) * 2016-11-28 2018-05-31 Koninklijke Philips N.V. Analytic prediction of antibiotic susceptibility

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
EP0361749B1 (de) * 1988-09-27 1995-02-08 Dana Farber Cancer Institute Vektor, der ein replikationskompetentes HIV-I-Provirus und ein heterologes Gen enthält
US5436131A (en) * 1993-04-02 1995-07-25 Merck & Co., Inc. Color screening assay for identifying inhibitor resistant HIV protease mutants
US5766842A (en) * 1994-09-16 1998-06-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of a protein to a drug targeted thereagainst
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6103462A (en) * 1998-05-29 2000-08-15 Institut Pasteur Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
MXPA00012843A (es) 1998-06-24 2002-04-24 Virologic Inc Medios y metodo para verificar la terapia antirretroviral con un inhibidor nucleosico de la transcriptasa inversa y guia de decisiones terapeuticas en el tratamiento del vih/sida.
US7138231B2 (en) * 2000-09-15 2006-11-21 Monogram Biosciences, Inc. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
EP1194587A4 (de) 1999-06-22 2005-07-06 Virologic Inc Mittel und verfahren zum überwachen von antiretroviralen therapien mit proteaseinhibitorenund entscheidungshilfe bei therapien in der behandlung von hiv/aids
US20030108857A1 (en) * 2001-06-04 2003-06-12 Parkin Neil T. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
WO2002022076A2 (en) 2000-09-15 2002-03-21 Virologic, Inc. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
EP1407042A4 (de) 2001-06-04 2006-02-22 Virologic Inc Mittel und verfahren zur überwachung einer antiretroviralen proteaseinhibitortherapie und als richtschnur für therapeutische entscheidungen bei der behandlung von hiv/aids
US7384734B2 (en) 2002-02-15 2008-06-10 Monogram Biosciences, Inc. Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
CA2491388A1 (en) * 2002-07-01 2004-01-08 Virologic, Inc. Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
CN1678755A (zh) 2002-07-01 2005-10-05 瓦罗洛吉克公司 确定致病性病毒对蛋白酶抑制剂易感性的组合物和方法

Also Published As

Publication number Publication date
US7384734B2 (en) 2008-06-10
TW200303362A (en) 2003-09-01
EP1483416B1 (de) 2012-02-01
CN1646704A (zh) 2005-07-27
AR038557A1 (es) 2005-01-19
WO2003070700A3 (en) 2004-02-26
CA2476403C (en) 2012-09-11
US20040224307A1 (en) 2004-11-11
AU2003211026A1 (en) 2003-09-09
EP1483416A4 (de) 2006-09-06
CA2476403A1 (en) 2003-08-28
ES2381866T3 (es) 2012-06-01
EP1483416A2 (de) 2004-12-08
WO2003070700A2 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
ATE543915T1 (de) Zusammensetzungen und verfahren zur bestimmung der empfindlichkeit eines pathogenen virus gegenüber proteaseinhibitoren
DE60309433D1 (de) Pharmazeutische zusammensetzungen für protease-hemmer für hepatitis-c-virus
DE60143233D1 (de) Verfahren zur Herstellung chiraler Bicycloprolinate als Intermediate zur Herstellung von Inhibitoren der peptidomimetischen Protease
ZA200607048B (en) Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
DE602004031298D1 (de) Makrocyclische inhibitoren der ns3-serinprotease des hepatitis-c-virus
ATE366735T1 (de) Polymorphe formen eines epothilon-analogons
IL176237A0 (en) Inhibitors of hepatitis c virus ns3/ns4a serine protease
DE60336177D1 (de) Auswertungsverfahren von Amplitudenwerten zur Ermittlung eines Slice-Level-Werts
ATE555388T1 (de) Onkolytische viren zur bestimmung des phänotypus von neoplasmen
DK1713822T3 (da) HCV NS-3 serine protease inhibitorer
DE602004005753D1 (de) Kombinationen von harzzusammensetzungen und verwendungsverfahren dafür
DE602005015834D1 (de) 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
ATE489370T1 (de) Herstellung und verwendung von verbindungen als aspartylproteasehemmer
DE502005007752D1 (de) Verfahren zur robotergestützten vermessung von messobjekten
DE50204531D1 (de) Verfahren und anordnung zur bestimmung der pufferwirkung einer batterie
DE50213797D1 (de) Verfahren und anordnung zur photogrammetrischen erfassung der raumform eines objekts
DE50305912D1 (de) Verfahren zur zerstörungsfreien prüfung eines bauteils
DE60214725D1 (de) Verfahren zur bestimmung der expression des dihydropyrimidindehydrogenasegens
DE50309469D1 (de) Verfahren und messgerät zur ortung eingeschlossener objekte
DE602004019385D1 (de) Verfahren und Anordnung von gebrauchsfertigen Reifen zur Sensorapplikation
DE60326196D1 (de) Vorrichtungen und Verfahren zur Ermittlung der N-beste Ketten eines Automaten
DE50309598D1 (de) Verfahren zur bestimmung der restlebensdauer eines schaltgerätes und zugehörige anordnung
DE50307262D1 (de) Verfahren und vorrichtung zur bestimmung der restlebensdauer eines schaltgerätes
DE602004026836D1 (de) Verfahren zur bestimmung der frequenzcharakteristik eines sperrfilters
DE60335409D1 (de) Verfahren zur bestimmung derpunktdefektverteilung eines siliciumeinkristallstabs